Amplifon | AMP - Cost Of Sales

Stock Price
13.86
Daily Change
0.08 0.54%
Monthly
-1.00%
Yearly
-46.90%
Q1 Forecast
13.18

Amplifon reported EUR460.17M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Amplifon EUR 460.17M 14.78M Sep/2025
Avanos Medical USD 91.8M 8.9M Sep/2025
Brookdale Senior Living USD 602.31M 42.07M Sep/2025
Cencora USD 80.77B 3.02B Sep/2025
Diasorin EUR 99.64M 4.71M Sep/2025
Encompass Health USD 150.9M 3.9M Dec/2025
Enovis USD 263.69M 18.96M Sep/2025
GE HealthCare Technologies USD 3.15B 131M Sep/2025
OPKO Health USD 104.78M 32.97M Sep/2025
Zimmer Biomet Holdings USD 735.8M 17M Sep/2025